Industry Briefs: May 14, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Company News
Almac has added the new PharmaWorks TF3, high-speed, large-format blister equipment, at its US headquarters in Souderton, Pennsylvania. Read More
GE Healthcare Life Sciences has completed its acquisition of Xcellerex. Read More
Molecular Profiles and GEA Process Engineering are collaborating to improve early screening of poorly water-soluble drugs and polymer compositions using the GEA Niro Drynetics single-particle spray-drying application.
Novozymes Biopharma has started to supply Novozymes Hyasis, a pharmaceutical-grade hyaluronic acid, from its recently opened facility in Tianjin, China. Read More
NSF-DBA has agreed with the Semler Research Center to expand pharmaceutical training, auditing, consulting, and testing services throughout India. Read More
People News
Cytovance Biologics has named Martin LeBlanc to its board of directors. Read More
Incline Therapeutics has appointed John Tucker as senior vice-president and chief commercial officer. Read More
Teva Pharmaceutical has appointed Michael Hayden as president of global R&D and chief scientific officer Read More